Unverified: The Claim That 44 Children Were Prescribed Puberty Blockers at WellBN
“44 children aged 16 and under (including 12 under 13) were prescribed puberty-suppressing drugs at WellBN”
The argument in brief
A claim circulating online states that 44 children aged 16 and under — including 12 under 13 — were prescribed puberty-suppressing drugs at WellBN, a GP federation in Brighton. This claim cannot be confirmed or denied: no publicly available data breaks down prescribing figures by age at this specific provider. The numbers sound precise, but precision is not the same as proof.
Why it spread
Exact numbers feel like inside knowledge — they suggest someone counted, someone investigated, someone knows. In a debate where people feel strongly about protecting children, a figure like '12 under 13' triggers an immediate emotional response that makes people share first and check later. The specificity does the work that evidence should do.
A specific claim has been spreading that WellBN, a GP federation in Brighton, prescribed puberty-suppressing drugs to 44 children aged 16 and under, including 12 children under the age of 13. The verdict is simple: this claim is unverifiable. That does not mean it is false — it means there is currently no publicly available evidence to confirm or deny it.
The core problem is a data gap. NHS England publishes aggregate figures on gender dysphoria services, but granular, clinic-level breakdowns by precise age groups for individual providers like WellBN are not in the public domain. NHS Sussex, which oversees WellBN-commissioned services, has not released patient-level prescribing data in any form that would settle this question.
The Cass Review (2024), an independent examination of NHS gender services for children, found serious concerns about data quality and record-keeping across gender clinics nationwide. That context matters: even official investigators struggled to get reliable numbers. If the Cass Review found the data hard to pin down, a specific figure circulating online should be treated with real caution.
The claim may have originated from a Freedom of Information request or a leaked document. If so, that primary source has not been made publicly available for independent scrutiny. Investigative outlets including The Times have reported on prescribing practices at various gender services, but specific figures attributed to WellBN require documentary evidence — an FOI response, a clinical record, an official dataset — before they can be treated as fact.
The strongest version of this claim is that it reflects a real document someone obtained but has not shared openly. That is possible. But a claim is not verified just because it is specific, and sharing unverified numbers in a highly charged debate about children's healthcare does real harm — it can distort policy discussions and damage trust in both directions. If you see this claim, ask one question: where is the original source document?
Sources
- NHS England / Cass Review
The Cass Review (2024) examined NHS gender services for children and found significant concerns about data quality and record-keeping at gender clinics, making precise patient numbers difficult to verify independently.
- Brighton and Hove Clinical Commissioning Group / NHS Sussex
WellBN (formerly Brighton and Hove CCG-commissioned service) has not publicly released detailed patient-level data on puberty blocker prescriptions broken down by age in a form that would confirm or deny this specific claim.
- NHS England Gender Services Data
NHS England has published aggregate data on gender dysphoria services but granular clinic-level breakdowns by specific age cohorts (e.g., under 13) for individual GP federations like WellBN are not publicly available in official datasets.
- The Times (UK) reporting on gender clinic prescriptions
UK investigative reporting has covered prescribing practices at various gender services, but specific figures attributed to WellBN require documentary evidence such as FOI responses or clinical records to verify.
Related debunks
- UnverifiableYes, Sterilizing Bugs Really Can Reduce Infectious Disease — Here's How It Works
- UnverifiableUnverifiable: The Claim That Claire Marks Caused a Contract Failure Due to Regulatory Restrictions
- Partially FalsePartially False: Rice Farmers Do Have Higher Arsenic Levels — But Compliant Rice Isn't the Main Culprit